EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieÄquivalenzstudie

A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation

Amir Moradi, Michael H Gold, David Hill, Hanna Dersch, Ross Radusky, Ute Schwab

Aesthetic Surgery Journal · 2026

DOI: 10.1093/asj/sjag200 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Surgery Journal, 2026. Verfasst von Amir Moradi und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyaluronic Acid, Lidocaine, Dermal Fillers, Lip Augmentation. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Merz North America, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lip augmentation with hyaluronic acid (HA)–based dermal fillers is commonly performed to enhance lip volume, shape, and symmetry.

Objectives

The aim of this study was to establish the safety and effectiveness of Belotero Intense with lidocaine (BIL), a cohesive polydensified matrix HA filler, for lip augmentation, and demonstrate its noninferiority to Restylane Silk with lidocaine (RSL), a US FDA-approved HA filler.

Methods

Patients with a Merz Lip Fullness Assessment Scale (MLFAS) rating of very thin, thin, or medium on upper and lower lips (Fitzpatrick skin type [FST] I-IV) or at least one lip (FST V or VI) were randomized 3:1 to receive BIL or RSL at baseline. Touch-up treatment was allowed at Week 4; retreatment at Week 48 was offered to BIL patients only. Primary effectiveness was assessed by a blinded evaluator using the MLFAS, and adverse events (AEs) were recorded up to 60 weeks.

Results

Belotero Intense with lidocaine achieved a Week 8 MLFAS-responder rate of 91.1% (144/158; 95% CI, 85.6-95.1), with the lower limit of the CI exceeding the prespecified 50% success criterion. The least squares mean difference in change from baseline vs RSL was 0.1 (95% CI, 0.0-0.3), meeting the prespecified noninferiority criterion (ie, lower CI limit >−0.5). Among Week 8 responders, 70/137 (51.1%) maintained improvement through Week 48 (post hoc analysis). No severe or serious related treatment-emergent AEs or unexpected AEs were reported.

Conclusions

Belotero Intense with lidocaine is a safe and effective treatment for lip augmentation in patients with upper and/or lower lip volume deficits. Level of Evidence: 1 (Therapeutic)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidLidocaineDermal FillersLip AugmentationLipAnesthetics, LocalHumansFemaleProspective StudiesMiddle AgedAdultTreatment OutcomeMaleSingle-Blind MethodDrug CombinationsCosmetic Techniques

Substanzen

Hyaluronic AcidLidocaineDermal Fillersbelotero balanceAnesthetics, LocalRestylaneDrug Combinations

Förderung

  • Merz North America, Inc.

Zitieren

APA

Moradi, A., Gold, M. H., Hill, D., Dersch, H., Radusky, R., & Schwab, U. (2026). A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjag200

Vancouver

Moradi A, Gold MH, Hill D, Dersch H, Radusky R, Schwab U. A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation. Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjag200

BibTeX
@article{Moradi2026,
  author = {Moradi, Amir and Gold, Michael H and Hill, David and Dersch, Hanna and Radusky, Ross and Schwab, Ute},
  title = {A Prospective, Multicenter, Evaluator-Blind, Randomized, Comparator-Controlled Study of Belotero Intense (+), a Hyaluronic Acid Filler With Lidocaine, for Lip Augmentation},
  journal = {Aesthetic Surgery Journal},
  year = {2026},
  doi = {10.1093/asj/sjag200}
}
Kostenlos starten →